Results 301 to 310 of about 883,694 (328)
Some of the next articles are maybe not open access.

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.

Critical Care Medicine, 1997
OBJECTIVES To determine and compare the respective concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, soluble TNF receptors, nitrite/nitrate (NO2-/NO3-), and procalcitonin in the plasma of patients with septic shock, cardiogenic ...
I. de Werra   +10 more
semanticscholar   +1 more source

Cardiogenic Shock

Chest, 1983
The definition, pathophysiology, and diagnosis of cardiogenic shock are presented. Its management is detailed, including specific forms of therapy for the various subgroups of patients in whom cardiogenic shock is an integral part. The choice of patients for and results of circulatory support using the intra-aortic balloon pump followed by early ...
openaire   +3 more sources

Revascularization in cardiogenic shock

Herz, 2020
Approximately 10% of patients with acute myocardial infarction develop cardiogenic shock. Randomized studies have shown a significant improvement in survival with early revascularization, which now represents the most important cornerstone in the treatment of infarct-related cardiogenic shock.
Anne Freund   +2 more
openaire   +2 more sources

Cardiogenic Shock

Critical Care Clinics, 2014
Cardiogenic shock is the most common cause of in-hospital mortality for patients who have suffered a myocardial infarction. Mortality exceeds 50% and management is focused on a rapid diagnosis of cardiogenic shock, restoration of coronary blood flow through early revascularization, complication management, and maintenance of end-organ homeostasis ...
Palak, Shah, Jennifer A, Cowger
openaire   +2 more sources

Laboratory Markers of Acidosis and Mortality in Cardiogenic Shock: Developing a Definition of Hemometabolic Shock

Shock, 2021
Supplemental Digital Content is available in the text ABSTRACT Background: Acidosis and higher lactate predict worse outcomes in cardiogenic shock (CS) patients.
J. Jentzer   +7 more
semanticscholar   +1 more source

SURGERY FOR CARDIOGENIC SHOCK

The Lancet, 1974
Abstract Eleven patients were consecutively operated upon for cardiogenic shock caused by myocardial infarction. The cardiogenic shock was refractory to conventional medical therapy. All eleven patients were dependent on intra-aortic counterpulsation balloon until after surgery.
M. G. Miller   +4 more
openaire   +4 more sources

Epidemiology and causes of cardiogenic shock

Current Opinion in Critical Care, 2021
Purpose of review Cardiogenic shock is a complex clinical syndrome of end-organ hypoperfusion due to impaired cardiac performance. Although cardiogenic shock has traditionally been viewed as a monolithic disorder predominantly caused by severe left ...
D. Berg, E. Bohula, D. Morrow
semanticscholar   +1 more source

Cardiogenic Shock in Women [PDF]

open access: possibleInterventional Cardiology Clinics, 2012
Cardiogenic shock (CS) describes the physiologic state in which reduced cardiac output and resultant tissue hypoxia occur in the presence of adequate intravascular volume. Among patients hospitalized with myocardial infarction (MI), CS is the foremost cause of death.
Roxana Mehran   +4 more
openaire   +2 more sources

Hemodynamics of Cardiogenic Shock

Interventional Cardiology Clinics, 2017
Cardiogenic shock (CS) represents an advanced state of morbidity along the pathophysiologic pathway of end-organ hypoperfusion caused by reduced cardiac output and blood pressure. Acute coronary syndromes remain the most common cause of CS. The spectrum of hypoperfusion states caused by low cardiac output ranges from pre-CS to refractory CS and can be ...
Jeffrey D. Wessler   +2 more
openaire   +3 more sources

Cardiogenic Shock

Critical Care Nursing Clinics of North America, 2011
Cardiogenic shock remains a significant issue and affects 5% to 10% of patients admitted with an AMI. Mortality remains high despite advances in treatment for AMI. These patients are best treated in centers where they can receive treatment that follows the joint guidelines recommended by ACC and AHA.
openaire   +2 more sources

Home - About - Disclaimer - Privacy